Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2000 | 12-1999 | 09-1999 | 06-1999 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 150 | 120 | 450 | 940 |
| Other current assets | 30 | 0 | 10 | 10 |
| TOTAL | $180 | $120 | $460 | $950 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | N/A | 70 |
| Other Non-Current Assets | 80 | 70 | 60 | 50 |
| TOTAL | $80 | $70 | $60 | $120 |
| Total Assets | $340 | $270 | $600 | $1,080 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 230 | 160 | 80 | 170 |
| Accrued Expenses | 70 | 6 | 10 | 3 |
| TOTAL | $310 | $160 | $90 | $170 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 10 | 10 | 10 | 0 |
| TOTAL | $10 | $10 | $10 | $N/A |
| Total Liabilities | $320 | $170 | $100 | $170 |
| Shareholders' Equity | ||||
| Common Shares | 60 | 60 | 60 | 5 |
| Retained earnings | -2,990 | -2,160 | -1,670 | -1,160 |
| Other shareholders' equity | -1,300 | -1,550 | -390 | -5 |
| TOTAL | $10 | $90 | $500 | $910 |
| Total Liabilities And Equity | $330 | $260 | $600 | $1,080 |